Private markets face a concentration test

Public equity markets have reached unprecedented concentration levels, with the ten largest stocks in the S&P 500 commanding nearly 40% of the index's total market capitalization. This concentration, driven substantially by the "Magnificent 7" technology stocks—Microsoft, Apple, NVIDIA, Amazon, Alphabet, Meta, and Tesla—vastly exceeds historical precedent. According to UBS analysis, the top-10 share during the dotcom bubble peaked at approximately 25%, while in 1980 it stood at just 15%. This structural vulnerability has intensified investor concern, particularly following recent tech sector weakness exemplified by Samsung and SK Hynix selloffs, which together accounted for roughly 60% of South Korea's stock market capitalization in Q1 2026.

This concentration dynamic has prompted institutional investors to reassess portfolio construction and seek diversification mechanisms outside traditional public equities. A 2026 Schroders survey indicates that half of equity and credit investors now evaluate both public and private markets simultaneously to achieve their portfolio objectives. Private markets offer an immediate structural advantage: they lack direct exposure to the "Magnificent 7" stocks driving current market concentration. This absence of exposure has made private markets increasingly attractive as a potential hedge against technology-driven volatility and downside protection during periods of public market disruption.

However, private markets do not entirely circumvent concentration risk. Richard Hickman, managing director of HarbourVest Global Private Equity, acknowledges that investors are actively searching for "a value story that is somewhat removed from the public markets," yet private equity and venture capital portfolios face their own concentration pressures. Concentration can manifest both at the sector level—through significant technology industry exposure—and at the company level, particularly through exposure to high-growth technology unicorns. The MSCI Global Venture Capital Index demonstrates this challenge, with the index's top 10 holdings accounting for a substantial portion of total holdings, suggesting that the diversification benefits of private markets relative to public equities may be more limited than surface-level analysis suggests.

The institutional shift toward evaluating private markets as an alternative return profile reflects genuine portfolio construction concerns about public market concentration, yet investors must carefully evaluate whether private market allocations genuinely provide the sector and thematic diversification necessary to hedge against technology concentration risk or simply replicate it through different vehicle structures.